CN101405010B - 避孕组合物 - Google Patents

避孕组合物 Download PDF

Info

Publication number
CN101405010B
CN101405010B CN2007800100366A CN200780010036A CN101405010B CN 101405010 B CN101405010 B CN 101405010B CN 2007800100366 A CN2007800100366 A CN 2007800100366A CN 200780010036 A CN200780010036 A CN 200780010036A CN 101405010 B CN101405010 B CN 101405010B
Authority
CN
China
Prior art keywords
salts
dendrimer
salt
pharmaceutically acceptable
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2007800100366A
Other languages
English (en)
Chinese (zh)
Other versions
CN101405010A (zh
Inventor
T·D·麦卡锡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Starpharma Pty Ltd
Original Assignee
Starpharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2006901474A external-priority patent/AU2006901474A0/en
Application filed by Starpharma Pty Ltd filed Critical Starpharma Pty Ltd
Publication of CN101405010A publication Critical patent/CN101405010A/zh
Application granted granted Critical
Publication of CN101405010B publication Critical patent/CN101405010B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/754—Dendrimer, i.e. serially branching or "tree-like" structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN2007800100366A 2006-03-22 2007-03-21 避孕组合物 Active CN101405010B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2006901474 2006-03-22
AU2006901474A AU2006901474A0 (en) 2006-03-22 Composition
PCT/AU2007/000352 WO2007106944A1 (en) 2006-03-22 2007-03-21 Contraceptive composition

Publications (2)

Publication Number Publication Date
CN101405010A CN101405010A (zh) 2009-04-08
CN101405010B true CN101405010B (zh) 2013-03-06

Family

ID=38521950

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007800100366A Active CN101405010B (zh) 2006-03-22 2007-03-21 避孕组合物

Country Status (8)

Country Link
US (1) US8193248B2 (enExample)
EP (1) EP1996209B1 (enExample)
JP (1) JP5322918B2 (enExample)
CN (1) CN101405010B (enExample)
AU (1) AU2007229268B2 (enExample)
CA (1) CA2640978C (enExample)
ES (1) ES2558875T3 (enExample)
WO (1) WO2007106944A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100324146A1 (en) * 2008-02-22 2010-12-23 Starpharma Pty Ltd Dendrimeric Enzyme Inhibitors
WO2010033188A2 (en) * 2008-09-16 2010-03-25 Playtex Products, Llc. Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
US20110077263A1 (en) * 2009-09-29 2011-03-31 University Of Southern California Methods and Compositions of Toll-Like Receptor (TLR) Agonists
US20110086044A1 (en) * 2009-09-29 2011-04-14 University Of Southern California Compositions and Methods to Inhibit HPV Infection
CA2836168C (en) * 2011-05-16 2019-09-24 Starpharma Pty Ltd Method of treatment or prophylaxis of bacterial vaginosis
US20140315795A1 (en) 2012-10-26 2014-10-23 Nlife Therapeutics, S.L. Compositions and Methods for Selective Delivery of Oligonucleotide Molecules to Cell Types
WO2014113693A1 (en) * 2013-01-18 2014-07-24 University Of Utah Research Foundation Modified release osmotic pump for ph-responsive intravaginal drug delivery
WO2016007538A1 (en) * 2014-07-07 2016-01-14 Prophylaxis, Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
US11071745B2 (en) 2014-07-07 2021-07-27 Elian Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
GB201617063D0 (en) * 2016-10-07 2016-11-23 Cambridge Design Research Llp Condoms

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1503816A (zh) * 2001-03-30 2004-06-09 ������ҩ�����޹�˾ 预防和治疗性传播疾病－i的药剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229490A (en) 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
GB9407812D0 (en) 1994-04-20 1994-06-15 Nycomed Salutar Inc Compounds
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
AUPO104496A0 (en) 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
US6191120B1 (en) * 1998-03-25 2001-02-20 Wayne Hughes Institute Spermicidally active 5-halo-6-alkoxy-5,6-dihydro-2′,3′-dideoxy-uridines and their pharamaceutical compositions
US6192887B1 (en) * 1998-05-19 2001-02-27 The Pennsylvania State University Broad spectrum microbicidal and spermicidal compositions and methods having activity against sexually transmitted agents including papillomaviruses
AUPP584398A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Inhibition of toxic materials or substances
AUPP584298A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Antimicrobial and antiparasitic agents
CA2402520A1 (en) * 2000-03-13 2001-09-20 Kenneth Beckman Biocidal methods and compositions
US6471968B1 (en) 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
CA2346188A1 (en) * 2001-05-02 2002-11-02 Bradley Benson Male sexual aid device
AU2003225636A1 (en) 2002-03-05 2003-09-22 Ramot At Tel-Aviv University Ltd. Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
JP2005527546A (ja) * 2002-03-26 2005-09-15 イースタン ヴァージニア メディカル スクール 局所用殺菌剤および避妊薬としてのスラミンおよびその誘導体

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1503816A (zh) * 2001-03-30 2004-06-09 ������ҩ�����޹�˾ 预防和治疗性传播疾病－i的药剂

Also Published As

Publication number Publication date
JP2009530316A (ja) 2009-08-27
EP1996209A1 (en) 2008-12-03
CN101405010A (zh) 2009-04-08
US8193248B2 (en) 2012-06-05
EP1996209A4 (en) 2010-04-21
ES2558875T3 (es) 2016-02-09
CA2640978C (en) 2016-01-19
WO2007106944A1 (en) 2007-09-27
AU2007229268A1 (en) 2007-09-27
CA2640978A1 (en) 2007-09-27
EP1996209B1 (en) 2015-11-04
US20090275507A1 (en) 2009-11-05
AU2007229268B2 (en) 2013-01-10
JP5322918B2 (ja) 2013-10-23

Similar Documents

Publication Publication Date Title
CN101405010B (zh) 避孕组合物
US6706276B2 (en) Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
AU2001243431A1 (en) Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
US11992472B2 (en) Compositions and methods for enhancing the efficacy of contraceptive microbicides
CN101172159A (zh) 酸性生物粘附热敏凝胶剂及其制法和用途
HK40021110A (en) Compositions and methods for enhancing the efficacy of contraceptive microbicides
Mburu et al. Safety studies of a recently developed microbicidal contraceptive gel (UniPron) in female baboons (Papioanubis)
Mburu ORIGINAL RESEARCH ARTICLE Safety Studies of a Recently Developed Microbicidal Contraceptive Gel (UniPron) in Female Baboons (Papio anubis)
OA17704A (en) Compositions and methods for enhancing the efficacy of contraceptive microbicides.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant